RxDoctor Payments Data

Shree Sharma, MD

Anatomic Pathology & Clinical Pathology · Little Rock, ARNPI 1487854923

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $12,344 of the $14,064 with a category attached, or 87.8%. Novartis accounts for 76.3% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $9,954 and has fallen 84.7% since, to $1,523 in 2025. Among anatomic pathology & clinical pathology clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,064in general payments, 2019–2025

Across 16 payments — averaging $879.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$11K
  • Vertex$3K
  • Roche Diagnostics Corporation$23
  • MDD US Operations, LLC$16
$110,975in research payments, 2019–2025

Across 2 payments — averaging $55,488 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Hoffmann-la Roche Limited$111K

What the payments were for

  • Consulting fees$12,34488%
  • Travel & lodging$1,36810%
  • Food & beverage$3533%

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$14,064 in reported general payments places this provider in the 95th percentile of 89 anatomic pathology & clinical pathology providers in Arkansas.

See all anatomic pathology & clinical pathology providers in Arkansas

Medicare billing

Part B allowed, 2024
$50,048
Medicare patients
123
Services billed
2,026

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →